Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2014
10/09/2014WO2014163413A1 Composition for life extension containing ginseng berry extract
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014163151A1 Yeast culture, and composition for internal application
10/09/2014WO2014163147A1 Salt of pyrazoloquinoline derivative, and crystal thereof
10/09/2014WO2014163146A1 Pyridinylpyrazoloquinoline compound
10/09/2014WO2014162925A1 Composition for preventing joint aging
10/09/2014US20140303257 Use of EDG Receptor Binding Agents in Cancer
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303126 Novel quinuclidine derivatives and medicinal compositions containing the same
10/09/2014US20140302600 Primate pluripotent stem cell expansion without feeder cells and in the presence of fgf and matrigel or engelbreth-holm-swarm tumor cell preaparation
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/08/2014EP2786996A1 Purinone derivative hydrochloride
10/08/2014EP2786751A1 Genistein for use in the method of mitigating detrimental effects of exposure to ionizing radiation
10/08/2014EP2786750A1 Agent for reducing adverse side effects of kinase inhibitor
10/08/2014EP2786741A1 Whitening cosmetic
10/08/2014EP2785738A1 Anti-npy and pyy antibodies and uses thereof
10/07/2014US8853415 Modulators of ATP-binding cassette transporters
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853265 Oral composition to reduce cold symptoms and duration of same
10/07/2014US8853160 GLP-1, exendin-4, peptide analogs and uses thereof
10/07/2014US8852860 Sperm-specific cation channel, CatSper1 and uses therefor
10/07/2014US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells
10/07/2014US8852551 Methods to impair hematologic cancer progenitor cells and compounds related thereto
10/02/2014WO2014160463A1 Prefusion rsv f proteins and their use
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157687A1 1,2,4-triazine-6-carboxamide derivative with acetamide group
10/02/2014WO2014157672A1 Substituted biaryl compound
10/02/2014WO2014157653A1 Processes for preparing optically active diamine derivatives
10/02/2014WO2014157607A1 Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof
10/02/2014WO2014157603A1 Pharmaceutical composition for oral administration
10/02/2014WO2014157569A1 Heterocyclic compound
10/02/2014WO2014157485A1 Peptide with anti-aging effect and use thereof
10/02/2014WO2014157444A1 Low-dose antitumor agent including irinotecan hydrochloride hydrate
10/02/2014WO2014157443A1 Antitumor agent including irinotecan hydrochloride hydrate
10/02/2014WO2014157429A1 Method for producing protein
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157257A1 Cell sorting method
10/02/2014WO2014157229A1 Tace peptide epitope, antihuman tace protein antibody and hybridoma producing antibody
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014157047A1 Therapeutic agent for neurodegenerative diseases
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/01/2014EP2784074A1 Pyrazole compound and use thereof for medical purposes
10/01/2014EP2782573A1 1,4- dihydropyridine derivatives with hsp modulating activity
09/2014
09/30/2014US8846906 5HT2C receptor modulators
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846650 Method of treating middle ear infections
09/30/2014US8846602 Process for producing an injectable medicament preparation
09/30/2014US8846401 Promoters exhibiting endothelial cell specificity and methods of using same
09/30/2014US8846101 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions
09/30/2014US8846030 Compounds and methods to enhance rAAV transduction
09/30/2014US8846024 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/25/2014WO2014152431A1 Stabilization of radioiodinated and astatinated pharmaceutials and imaging agents
09/25/2014WO2014148646A1 Pluripotent stem cell for neuronal differentiation induction
09/25/2014WO2014148620A1 Double-stranded nucleic acid binder, said binder—double-stranded nucleic acid complex, pharmaceutical composition containing said complex, and production method for said complex
09/25/2014WO2014148592A1 Method for preparing chondrocytes
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148438A1 Therapeutic agent for hepatitis c which comprises 4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzene derivative
09/25/2014WO2014148422A1 Licorice hydrolysis extraction composition
09/25/2014US20140288161 Urocortin-iii and uses thereof
09/25/2014US20140288114 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
09/25/2014US20140288034 Compound capable of binding s1p receptor and pharmaceutical use thereof
09/25/2014US20140287495 Methods of Inducing Differentiation of Stem Cells
09/24/2014EP2781599A1 Nucleic acid fragment binding to target protein
09/24/2014EP2781521A1 Novel spiroindoline compound, and medicinal agent comprising same
09/24/2014EP2781517A1 Nitrogenated heterocyclic compound
09/24/2014EP2781216A1 Chemokine receptor activity regulator
09/23/2014US8841322 Method for increasing the activity of lysosomal enzymes
09/23/2014US8841307 Method of using diketopiperazines and composition containing them
09/23/2014CA2651733C Guava leaf extract powder and method for production thereof
09/23/2014CA2602121C Pharmaceutical composition and method using an antifungal arylamidine in combination
09/18/2014WO2014146044A1 Administration of nicotinamide mononucleotide in the treatment of disease
09/18/2014WO2014145580A1 Neosaxitoxin combination formulations for prolonged local anesthesia
09/18/2014WO2014145389A1 Inhibition of pulmonary fibrosis with nutlin-3a and peptides
09/18/2014WO2014144075A1 Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis
09/18/2014WO2014143630A1 Polymorph forms of desazadesferrithiocin analogs
09/18/2014WO2014143453A1 Phosphodiesterase inhibitor treatment
09/18/2014WO2014142298A1 Novel hydroxamic acid derivative or salt thereof
09/18/2014WO2014142291A1 Hydrate of fluorine compound, and crystals thereof
09/18/2014WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor
09/18/2014WO2014142273A1 Dihydropyridazine-3,5-dione derivative
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014142220A1 Anti-tumor agent
09/18/2014WO2014142086A1 Pyrrolidin-3-yl acetate derivative and piperidin-3-yl acetate derivative
09/18/2014WO2014142056A1 Salt of pyrrolidin-3-yl acetic acid derivative and crystals thereof
09/18/2014WO2014141877A1 Tissue repair material
09/18/2014WO2014141847A1 Therapeutic agent for systemic bone disease and use thereof
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275225 Modulators of pharmacological agents
09/17/2014EP2776393A1 Nampt inhibitors
09/17/2014EP2776026A1 2-carboxamide cycloamino urea derivatives for use in treating vegf - dependent diseases
09/16/2014US8835500 Pharmaceutical formulations of amyloid inhibiting compounds
09/16/2014US8835438 Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835392 Mimetic peptides and the use thereof in the form of 20S, 26S and immunoproteasome inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 1564